Aberdeen, United Kingdom

Helen Christine Shiells

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Helen Christine Shiells: Innovator in Neurodegenerative Disorder Treatments

Introduction

Helen Christine Shiells is a prominent inventor based in Aberdeen, GB. She has made significant contributions to the field of medicine, particularly in the treatment of neurodegenerative disorders. With a total of 2 patents, her work focuses on optimizing dosage regimens for specific compounds.

Latest Patents

Helen's latest patents include innovative dosing regimens for Leuco-Methylthioninium (LMT) compounds. These inventions aim to maximize the proportion of subjects in which the MT concentration exceeds levels necessary for therapeutic efficacy in treating conditions such as Alzheimer's disease and frontotemporal dementias. Additionally, her patents provide LMT-containing dosage units and other compositions that maintain a desirable clinical profile.

Career Highlights

Helen Christine Shiells has established herself as a key figure in her field through her groundbreaking research and inventions. Her work has the potential to significantly impact the treatment landscape for neurodegenerative disorders, offering new hope to patients and healthcare providers alike.

Collaborations

Helen has collaborated with notable professionals in her field, including Claude Michel Wischik and Bjorn Olaf Schelter. These partnerships have further enhanced her research and development efforts.

Conclusion

Helen Christine Shiells is a remarkable inventor whose work in optimizing dosage regimens for neurodegenerative disorder treatments is paving the way for advancements in medical science. Her contributions are invaluable and continue to inspire innovation in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…